Want to see HRTX full AI Analyst Report?
Heron Therapeutics (HRTX) Income Statement
Heron Therapeutics Income Statement
Last quarter (Q2 2026), Heron Therapeutics's total revenue was $37.67M, an increase of 1.25% from the same quarter last year. In Q2, Heron Therapeutics's net income was $-5.49M. See Heron Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 154.90M | $ 144.28M | $ 127.04M | $ 107.67M | $ 86.35M | |
| $ 113.56M | $ 105.64M | $ 61.94M | $ 52.80M | $ 40.33M | |
| $ 116.09M | $ 117.17M | $ 172.55M | $ 227.46M | $ 258.15M | |
| Depreciation and Amortization | $ 2.31M | $ 2.49M | $ 2.90M | $ 2.89M | $ 3.02M |
| $ -17.88M | $ -5.06M | $ -103.79M | $ -176.66M | $ -215.25M | |
| $ -2.54M | $ -11.53M | $ -110.61M | $ -174.66M | $ -217.83M | |
| $ -17.66M | $ -2.05M | $ 56.00K | $ -7.37M | $ -2.85M | |
| $ -20.20M | $ -13.58M | $ -110.56M | $ -182.02M | $ -220.68M | |
| $ -20.20M | $ -13.58M | $ -110.56M | $ -182.02M | $ -220.68M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.12 | $ -0.09 | $ -0.80 | $ -1.67 | $ -2.24 |
| Diluted EPS | $ -0.12 | $ -0.09 | $ -0.80 | $ -1.67 | $ -2.24 |
| Weighted Average Shares Outstanding | 166.71M | 152.45M | 138.13M | 109.00M | 98.47M |
| Weighted Average Shares Outstanding (Diluted) | 166.71M | 152.45M | 138.13M | 109.00M | 98.47M |
Currency in USD
